AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence

MLA

Patrick M. McCarthy, et al. “AE37: A HER2-Targeted Vaccine for the Prevention of Breast Cancer Recurrence.” Expert Opinion on Investigational Drugs, vol. 30, Dec. 2020, pp. 5–11. EBSCOhost, https://doi.org/10.1080/13543784.2021.1849140.

APA

Patrick M. McCarthy, Timothy J. Vreeland, Anne E O’Shea, G. Travis Clifton, Alexandra M Adams, & George E. Peoples. (2020). AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence. Expert Opinion on Investigational Drugs, 30, 5–11. https://doi.org/10.1080/13543784.2021.1849140

Chicago

Patrick M. McCarthy, Timothy J. Vreeland, Anne E O’Shea, G. Travis Clifton, Alexandra M Adams, and George E. Peoples. 2020. “AE37: A HER2-Targeted Vaccine for the Prevention of Breast Cancer Recurrence.” Expert Opinion on Investigational Drugs 30 (December): 5–11. doi:10.1080/13543784.2021.1849140.